Sorry, but I just wanted to clarify a point on the primary endpoint of the trial ...
As per the trial protocol (https://clinicaltrials.gov/ct2/show/NCT02683629), the sole primary outcome measure was :
"The safety of xenotransplantation of NTCELL as measured by the incidence of adverse events related to treatment [ Time Frame: up to 26 weeks ] ".
This primary outcome has been achieved. There were no significant adverse effects.
The protocol also states that the various secondary outcomes were measured to 26 weeks and compared against the baseline .... the trial did not produce statistically significant improvements in this timeframe, which (in hindsight) was too short for the full benefits of the treatment to become apparent.
After 18 months, ""The principal investigator, Dr Barry Snow, Auckland City Hospital, says “The statistical improvement seen at 12 months has been sustained; variation between recipients is expected with the small number of subjects. The next step is further in-depth analysis to understand the data on all efficacy measurements both on and off normal symptomatic treatment.”" http://www.lctglobal.com/upload/news/2018/181102%20NTCELL%20Parkinsons%2018%20month.pdf
Looking forward to seeing the final results in June ...
- Forums
- ASX - By Stock
- Ann: CEO Presentation to the 2018 Annual General Meeting
Sorry, but I just wanted to clarify a point on the primary...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $15.18M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $9.66K | 1.206M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 313539 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1373312 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 313539 | 0.008 |
15 | 6171214 | 0.007 |
14 | 8160084 | 0.006 |
6 | 2510009 | 0.005 |
4 | 4065000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1373312 | 9 |
0.010 | 3949819 | 10 |
0.011 | 1490400 | 3 |
0.012 | 816363 | 4 |
0.013 | 41918 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online